文献速递慢性肾脏病水电解质与酸碱

血清骨化三醇浓度与老年人肾功能下降、心衰及死亡率的关系

Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study.
PubMed 文献 · Am J Kidney Dis · 2018-06-06

本研究基于Health ABC队列的病例-队列设计,在社区居住的70-79岁老年人中测量血清骨化三醇,随访10年。结果发现,骨化三醇浓度每降低1个标准差,主要肾功能下降风险增加30%(95%CI 1.03-1.65;P=0.03),但与心衰和全因死亡率无显著关联。

要点

  • 较低血清骨化三醇水平独立关联主要肾功能下降风险增加30%。
  • 骨化三醇与心衰发生及全因死亡率无显著关联。
  • 该关联不受慢性肾脏病状态或基线甲状旁腺激素、FGF23水平影响。

核心结论

  • 在社区居住的老年人中,较低的血清骨化三醇浓度与主要肾功能下降独立相关。

研究设计与样本

  • 病例-队列研究,纳入Health ABC研究中70-79岁功能良好的社区居住老年人,随机亚队列479人,另包括主要肾功能下降397例和心衰207例。

主要发现

  • 平均随访8.6年,亚队列中212人(44%)死亡。
  • 完全校正模型中,骨化三醇浓度每降低1个标准差,主要肾功能下降风险增加30%(95%CI 1.03-1.65;P=0.03)。
  • 骨化三醇与心衰发生风险无显著关联(HR 1.16;95%CI 0.94-1.47)。
  • 骨化三醇与全因死亡率无显著关联(HR 1.01;95%CI 0.81-1.26)。
  • 未观察到骨化三醇与慢性肾脏病状态、基线完整甲状旁腺激素或FGF23浓度间的显著交互作用。

临床怎么用

  • 在老年社区人群中,监测血清骨化三醇可能有助于识别肾功能下降高风险个体,但尚不能据此推荐干预。

局限性

  • 观察性研究设计。
  • 骨化三醇仅在单时间点测量。
  • 研究人群仅限于白人或黑人老年人,选择性较强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVES: Lower 25-hydroxyvitamin D concentrations have been associated with risk for kidney function decline, heart failure, and mortality. However, 25-hydroxyvitamin D requires conversion to its active metabolite, calcitriol, for most biological effects. The associations of calcitriol concentrations with clinical events have not been well explored. STUDY DESIGN: Case-cohort study. SETTING & PARTICIPANTS: Well-functioning community-living older adults aged 70 to 79 years at inception who participated in the Health, Aging, and Body Composition (Health ABC) Study. PREDICTOR: Serum calcitriol measured using positive ion electrospray ionization-tandem mass spectrometry. OUTCOMES: Major kidney function decline (≥30% decline in estimated glomerular filtration rate from baseline), incident heart failure (HF), and all-cause mortality during 10 years of follow-up. ANALYTIC APPROACH: Baseline calcitriol concentrations were measured in a random subcohort of 479 participants and also in cases with major kidney function decline [n=397]) and incident HF (n=207) during 10 years of follow-up. Associations of serum calcitriol concentrations with these end points were evaluated using weighted Cox regression to account for the case-cohort design, while associations with mortality were assessed in the subcohort alone using unweighted Cox regression. RESULTS: During 8.6 years of mean follow-up, 212 (44%) subcohort participants died. In fully adjusted models, each 1-standard deviation lower calcitriol concentration was associated with 30% higher risk for major kidney function decline (95% CI, 1.03-1.65; P=0.03). Calcitriol was not significantly associated with incident HF (HR, 1.16; 95% CI, 0.94-1.47) or mortality (HR, 1.01; 95% CI, 0.81-1.26). We observed no significant interactions between calcitriol concentrations and chronic kidney disease status, baseline intact parathyroid or fibroblast factor 23 concentrations. LIMITATIONS: Observational study design, calcitriol measurements at a single time point, selective study population of older adults only of white or black race. CONCLUSIONS: Lower calcitriol concentrations are independently associated with kidney function decline in community-living older adults. Future studies will be needed to clarify whether these associations reflect lower calcitriol concentrations resulting from abnormal kidney tubule dysfunction or direct mechanisms relating lower calcitriol concentrations to more rapid loss of kidney function.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Selamet U, Katz R, Ginsberg C, et al. Serum Calcitriol Concentrations and Kidney Function Decline, Heart Failure, and Mortality in Elderly Community-Living Adults: The Health, Aging, and Body Composition Study. Am J Kidney Dis. 2018. PMID: 29885925. doi:10.1053/j.ajkd.2018.03.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。